- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04033003
Group Antenatal Care and Delivery Project (GRAND)
Group Antenatal Care to Promote a Healthy Pregnancy and Optimize Maternal and Newborn Outcomes: A Cluster Randomized Controlled Trial
Antenatal care (ANC) has the potential to play a pivotal role in ensuring positive pregnancy outcomes for both mothers and their newborns. A critical component of all ANC is teaching women to recognize the major complications that account for the majority of preventable maternal and newborn deaths. Antenatal care provides an opportunity to promote a healthy lifestyle, to integrate positive health behaviors, and to develop a trusting relationship with a provider and the health system. While group ANC has been delivered and studied in high-resource settings for over a decade, it has only recently been introduced as an alternative to individual care in sub-Saharan Africa.
The goal of this research is to improve health literacy and reduce preventable maternal and newborn morbidities and mortality within highly vulnerable, low and non-literate populations that assume a disproportionate burden of poor pregnancy outcomes globally. This research examines a bold, new approach to ANC that takes provision of care out of clinic exam rooms into small groups of women grouped by gestational age in low resource settings with low and non-literate populations. Group ANC has the potential to shift the current clinical practice paradigm of antenatal care for highly vulnerable women to improve maternal and newborn outcomes both globally and domestically.
The investigators hypothesize that pregnant women randomized into group ANC will exhibit increased health literacy through: 1) increased birth preparedness and complication readiness (BPCR), including recognition of danger signs and knowledge of how to respond to such signs; 2) higher rates of care-seeking behaviors, including seeking care for problems identified during pregnancy, higher facility delivery rates, and increased attendance at postnatal and postpartum care; and 3) better clinical outcomes for themselves and their newborns than women who received the routine, individual ANC.
Study Overview
Detailed Description
We are at a critical time to examine new, innovative strategies to promote healthy pregnancy and optimize maternal and newborn outcomes. Generating successful strategies will require careful examination of existing service delivery models, challenging the current structure of care provision. One aspect of care, recently identified by the World Health Organization, which merits further research, is group antenatal care (ANC).
Since ANC is widely available and attended by the majority of pregnant women in Ghana without the expected impact on birth outcomes, it is vital to examine the way antenatal health messages are delivered. Pregnant women must receive health information that is accurate and easy to understand for them to make informed choices to improve their health and the health of their baby. A critical component of all ANC is teaching women to recognize the major complications that account for the majority of preventable maternal and newborn deaths. Antenatal care provides an opportunity to promote a healthy lifestyle, to integrate positive health behaviors, and to develop a trusting relationship with a provider and the health system. Interactions during ANC provide the opportunity to identify and treat numerous problems, as well as providing a setting to improve women's health literacy. Patients must receive health messages in a manner that allows them to process and evaluate the information and ultimately use it to impact their own health.
The effectiveness of ANC depends on the multidimensional concept of health literacy. Initially considered only as a patient's ability to read and understand written information, it is now more broadly defined as a person's ability to acquire or access information, understand it, and use the information in ways that promote and maintain good health. Despite a burgeoning emphasis on health literacy in high resource countries, there are a dearth of studies examining interventions to improve health literacy in low-resource settings. Even fewer studies have examined maternal health literacy, defined as the "cognitive and social skills which determine the motivation and ability of women to gain access to, understand, and use information in ways that promote and maintain their health and that of their children''. New approaches to improve health literacy are sorely needed in countries where women and newborns continue to die from preventable causes.
Antenatal care has been delivered the same way for decades. Clinics and hospitals in low-resource countries are notorious for providing ethnocentric care, privileging northern medical values at the expense of traditional and community values. Yet health literacy is affected by the cultural context in which learning takes place, including, but not limited to, belief systems, traditions, understanding, and communication styles. Transmitting health information in a clinical setting often fails to take into account the social and economic circumstances of patients, therefore not achieving the expected impact on health behaviors. This divide has contributed to a lack of progress in reaching the most vulnerable populations. If pregnant women do not receive health messages in a comprehensible way, they cannot effectively maximize the benefits of the health system. Substantially improving women's ability to understand and utilize health information is of utmost importance if we are to reach the global targets of 70 maternal deaths per 100,000 live births by 2030 and a neonatal mortality rate of 12 per 1000 live births set by WHO/USAID.
The investigators hypothesize that pregnant women randomized into group ANC will exhibit increased health literacy through:
- Increased BPCR, including recognition of danger signs and knowledge of how to respond to such signs
- Higher rates of care-seeking behaviors, including seeking care for problems identified during pregnancy, higher facility delivery rates, and increased attendance at postnatal and postpartum care
- Better clinical outcomes for themselves and their newborns than women who received the routine, individual ANC.
The intervention consists of nine meetings; one individual meeting and eight group meetings. At the initial ANC visit, women are assigned to a small groups with up to14 women of similar gestational age. Women meet individually with the midwife and the standard history and physical exam as well as lab tests are completed; group visits start at the second ANC visit. Prior to the start of each group, blood pressure, weight, and a urinalysis are measured for each woman. The midwife, health facility staff member, and patients then sit in circle facing one another for a 60-90 minute facilitated discussion. The health facility staff member will assist the midwife with group activities. The model uses strategies such as story-telling, peer support, and demonstration and teach-back to enhance its effectiveness. Health literacy is incorporated as an integral part of clinical practice within the model - not as an add-on to care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Adawso, Ghana
- Adawso Health Center
-
Adukrom, Ghana
- Adukrom Health Center
-
Agogo, Ghana
- Klo Agogo Polyclinic
-
Akropong, Ghana
- Abiriw Clinic
-
Akropong, Ghana
- St Martin's Hospital
-
Akuse, Ghana
- Akuse Hospital
-
Koforidua, Ghana
- Nkurakan Health Center
-
Mampong, Ghana
- Tetteh Quarshie Hospital
-
Nsawam, Ghana
- Adoagyiri Health Center
-
Nsawam, Ghana
- Djankrom Health Center
-
Nsawam, Ghana
- Nsawam Health Center
-
Nsawam, Ghana
- Nsawam Hospital
-
Somanya, Ghana
- Atua Hospital
-
Somanya, Ghana
- Somanya Polyclinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- willingness to participate in the study
- less than 20 weeks' gestation 3) able to speak Dangme, Ga, Akan, Ewe, or English
- over the age of 15 years
Exclusion Criteria:
- No history of medical problems that would indicate the participant might be considered "high risk" (e.g., hypertension, insulin-dependent diabetes mellitus) and thus requiring a more individualized approach to care.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group ANC
Intervention groups consist of up to 14 women of similar gestation age (10 to 20 weeks) for nine meetings.
The first meeting is an individual meeting with the midwife and the standard history and physical exam as well as lab tests are completed.
Group meetings are held once a month until 28 weeks of pregnancy, then every 2 weeks until 34 weeks of pregnancy, and the remaining group meetings are once a week.
Prior to the start of each group, blood pressure, weight, and a urinalysis are measured for each woman.
|
Intervention groups of up to 14 women of similar gestation age (10 to 20 weeks) for nine meetings.
The first meeting is an individual meeting with the midwife and the standard history and physical exam as well as lab tests are completed.
Group meetings are held once a month until 28 weeks of pregnancy, then every 2 weeks until 34 weeks of pregnancy, and the remaining group meetings are once a week.
Prior to the start of each group, blood pressure, weight, and a urinalysis are measured for each woman.
|
No Intervention: Stand ANC
Individual standard antenatal care delivered at health facilities in Ghana
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Ability to Identify Danger Signs in Pregnancy
Time Frame: T0 Baseline (at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Ability to identify danger signs in pregnancy will be measured utilizing a self-report, open ended, question that asks participants to identify warning signs that may occur during pregnancy (e.g. headache, vision changes, fever, vaginal bleeding, swollen face, etc.). There is no validated or standardized instrument to measure Birth Preparedness and Complication Readiness (BPCR). The measure used in this study is an open-end question: What are the danger signs during pregnancy? Things that might mean there is a problem with you or the baby. Fourteen possible correct responses; raw item scores are a sum of individual responses; scores range from 0 to 14. Reported results are the average of all individual scores within the study arm. Change will be measured by calculating the difference in the mean at T0 and T1. Higher score means a better outcome. |
T0 Baseline (at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Change in Birth Preparedness and Complication Readiness
Time Frame: T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Change in the ability to identify a strategy for birth preparedness and complication readiness (BPCR) will be measured using a binary response (yes/no) to a question that ask participants if they have: (1) saved money, (2) identified birth facility for delivery, (3) identified emergency transportation to the facility, and (4) identified a blood donor.
There is no validated or standardized instrument to measure BPCR.
The measure used in this study is an open-end question: What are some things a woman can do to prepare for birth?
Eleven possible correct responses; raw item scores are a sum of individual responses; scores range from 0 to 11. Reported results are the average of all individual scores within the study arm.
Change will be measured by calculating the difference in the mean at T0 and T1.
Higher score means a better outcome.
|
T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Change in Ability to Identify Newborn Danger Signs
Time Frame: T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Ability to identify newborn danger signs will be measured utilizing a self-report, open ended, question that asks participants to identify newborn danger signs that may occur after delivery (e.g. poor suck, jaundice, difficulty/fast breathing, and convulsions). Change will be measured by calculating the difference in the mean at T0 and T1. There is no validated or standardized instrument to measure Birth Preparedness and Complication Readiness (BPCR). The measure used in this study is an open-end question: What are the danger signs for your newborn? Things that might mean there is a problem. Thirteen possible correct responses; raw item scores are a sum of individual responses; scores range from 0 to 13. Reported results are the average of all individual scores within the study arm. Higher score means a better outcome. |
T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Attendance of ANC Visits
Time Frame: T2 (6-12 weeks after delivery)
|
Attendance of 4 or more ANC visits will be gleaned from data reported on the participant's ANC/health card.
|
T2 (6-12 weeks after delivery)
|
Place of Delivery
Time Frame: T2 (6-12 weeks after delivery)
|
Place of delivery will be measured using a self-report question (facility delivery, home delivery).
|
T2 (6-12 weeks after delivery)
|
Attendance at Postpartum Check-ups for Mother
Time Frame: T2 (6-12 weeks after delivery)
|
Attendance of postpartum check-ups will be gleaned from information on the participant's ANC/health card.
|
T2 (6-12 weeks after delivery)
|
Attendance at Postnatal Check-up for Newborn
Time Frame: T2 (6-12 weeks after delivery)
|
Attendance of postnatal checkup will be gleaned from information on the participant's ANC/health card using a measure of 3 visits before 6 weeks for newborns.
|
T2 (6-12 weeks after delivery)
|
Birth Outcome
Time Frame: T2 (6-12 weeks after delivery)
|
Birth outcomes will be self-reported and measured as stillbirth, live birth, early neonatal mortality.
|
T2 (6-12 weeks after delivery)
|
Change in Health Literacy
Time Frame: T0 (Baseline at recruitment) and T2 (6 - 12 weeks postdelivery)
|
Change in Health Literacy will be measured using the Maternal Health Literacy Scale. Change over time will be analyzed using between group analysis and calculating the difference in the mean from T0 to T2. Maternal Health Literacy (MaHeLi) scale is a validated measure that consists of 12 yes-or-no questions to assess maternal health literacy among the participants. Raw item scores are a sum of individual responses; scores range from 0 to 12. Reported results are the average of all individual scores within the study arm. Higher score means a better outcome. |
T0 (Baseline at recruitment) and T2 (6 - 12 weeks postdelivery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Ability to Identify Postpartum Danger Signs for Mother
Time Frame: T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Ability to identify danger signs after delivery will be measured utilizing a self-report, open ended, question that asks participants to identify warning signs that may occur after delivery (e.g.
increased bleeding or large clots; weakness/fainting; fever; pain in abdominal or breast; painful urination, etc.).
Change will be measured by calculating the difference in the mean at baseline and 3rd trimester.
|
T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery)
|
Change in Ability to Identify the Recommended Action Steps When a Problem is Identified
Time Frame: Baselin) and 3rd trimester
|
Ability of mother to identify recommended action steps in response to danger signs will be measured by self-report using a question that asks participants to identify care-seeking behaviors to respond to danger signs that may occur before or after delivery (e.g.
call for help, go to the hospital or health facility, identify someone to accompany you to the facility).
Change will be measured by calculating the difference in the mean at baseline and 3rd trimester.
|
Baselin) and 3rd trimester
|
Change in Knowledge of Family Planning Methods
Time Frame: Baseline and 3rd trimester
|
Knowledge of family planning methods will be measured by self-report using a question that asks participants to identify all the methods of family planning they know.
Change will be measured by calculating the difference in the mean at baseline and 3rd trimester.
|
Baseline and 3rd trimester
|
Change in Intent to Use Family Planning
Time Frame: Baseline and 3rd trimester
|
Intent to use family planning methods will be measured by self-report using a binary (yes/no) question that asks participants their intent to use family planning after delivery.
Change over time will be analyzed using between group analysis and calculating the difference in the mean from baseline to 3rd trimester
|
Baseline and 3rd trimester
|
Change in Uptake of Family Planning
Time Frame: 6 weeks post-delivery, 6 months post-delivery, and 1 year post-delivery
|
Uptake of family planning will be measured by self-report using a questionnaire that asks participants if they are currently using family planning after delivery.
Change over time will be analyzed using between group analysis and calculating the difference in the mean from baseline to 3rd trimester
|
6 weeks post-delivery, 6 months post-delivery, and 1 year post-delivery
|
Change in Interpersonal Violence
Time Frame: Baseline and 1 year post-delivery
|
Interpersonal violence will be measured by self-report using a binary (yes/no) questionnaire that asks participants if they experienced violence in the past year, and if resources and support are available to them.
Change over time will be analyzed using between group analysis and calculating the difference in the mean from baseline to 3rd trimester
|
Baseline and 1 year post-delivery
|
Experience of ANC Care
Time Frame: 6 weeks post-delivery
|
Experience of ANC care will be measured by self-report using a binary (yes/no) questionnaire that asks participants about their experience regarding respectful care, satisfaction with care, and experience such as privacy and treatment with health system during their ANC visits.
|
6 weeks post-delivery
|
Completion of IPTp2 Malaria Prophylaxis During Pregnancy
Time Frame: 3rd Trimester
|
Data gleaned from the participant's ANC/health record will be used to measure affirmative completion of IPTp2 malaria prophylaxis during pregnancy.
|
3rd Trimester
|
Completion of Least Two Tetanus Toxoid Vaccines During Pregnancy
Time Frame: 3rd trimester
|
Data gleaned from the participant's ANC/health record will be used to measure if the participant received least two tetanus toxoid vaccines during pregnancy.
|
3rd trimester
|
Newborn Weight in kg
Time Frame: 6 weeks post-delivery
|
Newborn weight in kg; these data will be retrieved from the participant's ANC/health card and measured as newborn weight in kg.
|
6 weeks post-delivery
|
Mother's Hemoglobin at Delivery in Grams Per Deciliter (g/dl).
Time Frame: 6 weeks post-delivery
|
Mother's hemoglobin at delivery; these data will be retrieved from the participant's ANC/health card and measured as hemoglobin in grams per deciliter (g/dl).
|
6 weeks post-delivery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: John EO Williams, Dodowa Health Research Centre
- Principal Investigator: Jody R Lori, PhD, University of Michigan
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HUM00161464
- R01HD096277 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antenatal Care
-
JhpiegoBill and Melinda Gates Foundation; Addis Continental Institute of Public HealthTerminated
-
Peking University Third HospitalPeking University; Peking University China Center for Health Development StudiesEnrolling by invitation
-
Karolinska InstitutetUppsala University; Dalarna University; La Trobe UniversityTerminated
-
Heidelberg UniversityKarolinska Institutet; University Ghent; Centre de Recherche en Sante de Nouna... and other collaboratorsUnknownAntenatal Care and DeliveryGermany
-
Bridge to Health Medical and DentalKigezi Healthcare FoundationCompletedMaternal Health | Antenatal Care
-
Hiroshima UniversityNorth South University; Obstetrical and Gynaecological Society of Bangladesh...RecruitingReduce Unnecessary Caesarean Section | Increase Institutional Delivery | Increase Antenatal CareBangladesh
-
University of British ColumbiaHelen Keller International; Vitamin AngelsEnrolling by invitationPregnancy Related | Antenatal Care | Iron Folic Acid SupplementationCambodia
-
Necmettin Erbakan UniversityCompletedMental Health | Antenatal CareTurkey
-
Rush University Medical CenterUniversity of Wisconsin, Milwaukee; Advocate Health Care; Children's Bureau -... and other collaboratorsRecruitingPregnancy Related | Parent-Child Relations | Parenting | Education | Antenatal Care | CounselingUnited States
Clinical Trials on Group ANC
-
University of California, San FranciscoUniversity of Rwanda; Ministry of Health, Rwanda; Rwanda Biomedical CentreCompletedPregnancy Complications | Preterm Birth | Low Birth Weight | Preterm Labor | Stillbirth | Neonatal MortalityRwanda
-
PATHCenters for Disease Control and Prevention; Ministry of Health, Mozambique; Tropical...Completed
-
PATHCenters for Disease Control and Prevention; Centre national de recherche et...Completed
-
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.Active, not recruitingMajor Depressive DisorderUnited States
-
Imperial College LondonUniversity of Cape TownCompleted
-
University of California, San FranciscoCenters for Disease Control and Prevention; Kenya Medical Research InstituteCompletedHIV InfectionsKenya
-
Hiroshima UniversityNorth South University; Obstetrical and Gynaecological Society of Bangladesh...RecruitingReduce Unnecessary Caesarean Section | Increase Institutional Delivery | Increase Antenatal CareBangladesh
-
International Centre for Diarrhoeal Disease Research...Penn State University; Government of Bangladesh; World Bank; UNICEF; Sight and Life...RecruitingMaternal Nutritional Deficiency During ChildbirthBangladesh
-
Liverpool School of Tropical MedicineKenya Medical Research Institute; LVCT HealthNot yet recruitingPregnancy | Health Systems | Electronic Community Health Information Systems | Antenatal Clinic Uptake
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand